Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department
Jean-Claude NguyenVan(Hôpital Paris Saint-Joseph), Alban Le Monnier(Université Paris-Saclay), Vincent Enouf(Université Claude Bernard Lyon 1), O. Ganansia(Hôpital Paris Saint-Joseph), Amir Khaterchi(Hôpital Paris Saint-Joseph), Assaf Mizrahi(Université Paris-Saclay), Camille Gerlier(Hôpital Saint Joseph), Gauthier Péan de Ponfilly(Hôpital Paris Saint-Joseph), B. Pilmis(Hôpital Necker-Enfants Malades)
Cited by 26
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Listeria rocourtiae sp. nov.
|INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY|2009|189
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy
|Journal of Infection|2016|167
Evaluation of the Andromas Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Identification of Aerobically Growing Gram-Positive Bacilli
|Journal of Clinical Microbiology|2012|137
Overnight Stay in the Emergency Department and Mortality in Older Patients
|JAMA Internal Medicine|2023|130